Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.

 
Web www.patentalert.com

< (none)

< Inhibition of neonatal hyperbilirubinemia in breast fed infants

> Method and apparatus for treating obesity and for delivering time-released medicaments

> (none)
~ 00084